title: Effective symptomatic medication should be available in prophylactic trials in cluster headache.
authors.forename: Peer
authors.initials: P
authors.lastname: Tfelt-Hansen
mesh_terms: D002227:Carbazoles / Q000627:therapeutic use*; D003027:Cluster Headache / Q000517:prevention & control*; D017408:Guidelines as Topic; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D018170:Sumatriptan / Q000627:therapeutic use*; D016896:Treatment Outcome; D014363:Tryptamines / Q000627:therapeutic use*
chemical_list: D002227:Carbazoles; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D018170:Sumatriptan; C108128:frovatriptan